Selective serotonin reuptake inhibitor-induced sexual dysfunction

Journal of Sexual Medicine

Volumn 6, Issue 5, 2009, Pages 1259-1269

  Corona, Giovanni ^a,b   Ricca, Valdo ^a   Bandini, Elisa ^a   Mannucci, Edoardo ^a   Lotti, Francesco ^a   Boddi, Valentina ^a   Rastrelli, Giulia ^a   Sforza, Alessandra ^b   Faravelli, Carlo ^a   Forti, Gianni ^a   Maggi, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b BELLARIA HOSPITAL   (Italy)

Author keywords

Delayed ejaculation; Erectile dysfunction; Hyperprolactinemia; Hypoactive sexual desire; NCEP ATPIII = national cholesterol education program third adult treatment panel; SSRI

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; MONOAMINE OXIDASE A INHIBITOR; PAROXETINE; PROLACTIN; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG USE; EJACULATION DISORDER; ERECTILE DYSFUNCTION; HIGH RISK POPULATION; HUMAN; LIBIDO DISORDER; LIFE STRESS; MAJOR CLINICAL STUDY; MALE; MASTURBATION; MENTAL DISEASE; ORGASM; PENILE BLOOD FLOW; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RISK FACTOR; SEXUAL AROUSAL; SEXUAL DYSFUNCTION;

EID: 65149097788     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01248.x     Document Type: Article

References (55)

1. Masters WH, Johnson VE. Human sexual inadequacy. Boston: Little Brown; 1970.
2. Petrone L, Mannucci E, Corona G, Bartolini M, Forti G, Giommi R, Maggi M. Structured interview on erectile dysfunction (SIEDY©): A new multidimensional instrument for quantification of pathogenetic issue on erectile dysfunction. Int J Impot Res 2003;15:210-20.
3. Sommer F, Obenaus K, Engelmann U. Creative-dynamic image synthesis: A useful addition to the treatment options for impotence. Int J Impot Res 2001;13:268-74.
4. Corona G, Mannucci E, Petrone L, Ricca V, Balercia G, Giommi R, Forti G, Maggi M. Psycho-biological correlates of free-floating anxiety symptoms in male patients with sexual dysfunctions. J Androl 2006;27:86-93.
5. Bodner DR. Impotence: Evaluation and treatment. Prim Care 1985;12:719-33.
6. Hendry WF, Althof SE, Benson GS. Male orgasmic and ejaculatory disorders. In: Jardin A, Wagner G, Khoury S, eds. Erectile dysfunction, proceeding of the 1st international consultation on erectile dysfunction. Plymouth: Health Publications Ltd; 2000:477-506.
7. Melnik T, Soares BG, Nasello AG. The effectiveness of psychological interventions for the treatment of erectile dysfunction: Systematic review and meta-analysis, including comparisons to Sildenafil treatment, intracavernosal injection, and vacuum devices. J Sex Med 2008;5:2562-74.
8. Corona G, Ricca V, Bandini E, Mannucci E, Petrone L, Fisher AD, Lotti F, Balercia G, Faravelli C, Forti G, Maggi M. Association between psychiatric symptoms and erectile dysfunction. J Sex Med 2008;5:458-6.
9. MacGillivray S, Arroll B, Hatcher S, Ogston S, Reid I, Sullivan F, Williams B, Crombie I. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: Systematic review and meta-analysis. BMJ 2003;326:1014.
10. Culpepper L. Generalized anxiety disorder in primary care: Emerging issues in management and treatment. J Clin Psychiatry 2002;63(8 suppl):35-42.
11. Geddes JR, Freemantle N, Mason J, Eccles MP, Boynton J. SSRIs vs. other antidepressants for depressive disorder. Cochrane Database Syst Rev 2000;2: CD 001851.
12. Worthington JJ 3rd, Peters PM. Treatment of antidepressant-induced sexual dysfunction. Drugs and Today (Barc) 2003;39:887-96.
13. Cassano P, Fava M. Tolerability issues during long-term treatment with antidepressants. Ann Clin Psychiatry 2004;16:15-25.
14. Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry 2000;61:276-81.
15. Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, Bass KI, Donahue RM, Jamerson BD, Metz A. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002;63:357-66.
16. Nurnberg HG, Hensley PL, Gelenberg AJ, Fava M, Lauriello J, Paine S. Treatment of antidepressant-associated sexual dysfunction with sildenafil: A randomized controlled trial. JAMA 2003;289:56-64.
17. Segraves RT. Antidepressant-induced sexual dysfunction. J Clin Psychiatry 1998;59(4 suppl):48-54.
18. Labbate LA, Croft HA, Oleshansky MA. Antidepressant-related erectile dysfunction: Management via avoidance, switching antidepressants, antidotes, and adaptation. J Clin Psychiatry 2003;64(10 suppl):11-9.
19. Rosen RC, Marin H. Prevalence of antidepressant-associated erectile dysfunction. J Clin Psychiatry 2003;64(10 suppl):5-10.
20. Ferguson JM. The effects of antidepressants on sexual functioning in depressed patients: A review. J Clin Psychiatry 2001;62(3 suppl):22-34.
21. Balon R. SSRI-associated sexual dysfunction. Am J Psychiatry 2006;163:1504-9.
22. Safarinejad MR. Evaluation of endocrine profile and hypothalamic-pituitary-testis axis in selective serotonin reuptake inhibitor-induced male sexual dysfunction. J Clin Psychopharmacol 2008;28:418-23.
23. Clayton A, Keller A, McGarvey EL. Burden of phase-specific sexual dysfunction with SSRIs. J Affect Disord 2006;91:27-32.
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edn. (Text revision ed.). Washington, DC: American Psychiatric Association; 2000.
25. Crown S, Crisp AH. A short clinical diagnostic self-rating scale for psychoneurotic patients. The Middlesex Hospital Questionnaire (M.H.Q.). Br J Psychiatry 1966;112:917-23.
26. Corona G, Petrone L, Mannucci E, Ricca V, Balercia, G; Giommi R, Forti G, Maggi M. The impotent couple: Low desire. Int J Androl 2005;28:46-52.
27. Corona G, Mannucci E, Petrone L, Fisher AD, Balercia G, De Scisciolo G, Pizzocaro A, Giommi R, Chiarini V, Forti G, Maggi M. Psychobiological correlates of delayed ejaculation in male patients with sexual dysfunctions. J Androl 2006;27:453-8.
28. Fisher AD, Corona G, Bandini E, Mannucci E, Lotti F, Boddi V, Forti G, Maggi M. Psychobiological correlates of extramarital affairs and differences between stable and occasional infidelity among men with sexual dysfunction. J Sex Med 2009 Jan 8. [Epub ahead of print].
29. Corona G, Petrone L, Mannucci E, Jannini EA, Mansani R, Magini A, Giommi R, Forti G, Maggi M. Pshycho-biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunction. Eur Urol 2004;46:615-22.
30. Corona G, Jannini EA, Mannucci E, Fisher AD, Lotti F, Petrone L, Balercia G, Bandini E, Chiarini V, Forti G, Maggi M. Different testosterone levels are associated with ejaculatory dysfunction. J Sex Med 2008;5:1991-8.
31. Taylor MJ, Rudkin L, Hawton K. Strategies for managing antidepressant-induced sexual dysfunction: Systematic review of randomised controlled trials. J Affect Disord 2005;88:241-54.
32. Corona G, Mannucci E, Fisher AD, Lotti F, Ricca V, Balercia G, Petrone L, Forti G, Maggi M. Effect of hyperprolactinemia in male patients consulting for sexual dysfunction. J Sex Med 2007;4:1485-93.
33. Buvat J. Hyperprolactinemia and sexual function in men: A short review. Int J Impot Res 2003;15:373-7.
34. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: A critical review. J Clin Psychopharmacol 1999;19:67-85.
35. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients. J Clin Psychiatry 2001;62(3 suppl):10-2.
36. Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry 2000;57:1012-30.
37. Argiolas A, Melis MR. The neurophysiology of the sexual cycle. J Endocrinol Invest 2003;26(3 suppl):20-2.
38. Miner MM, Seftel AD. Centrally acting mechanisms for the treatment of male sexual dysfunction. Urol Clin North Am 2007;34:483-96.
39. Stimmel GL, Gutierrez MA. Pharmacologic treatment strategies for sexual dysfunction in patients with epilepsy and depression. CNS Spectr 2006;11(8 suppl 9):31-7.
40. Feldman HA, Goldstein I, Hatzichristou G, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts male aging study. J Urol 1994;151:54-61.
41. Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB. The relationship between depressive symptoms and male erectile dysfunction: Cross-sectional results from the Massachusetts male aging study. Psychosom Med 1998;60:458-65.
42. Hirshkowitz M, Schmidt MH. Sleep-related erections: Clinical perspectives and neural mechanisms. Sleep Med Rev 2005;9:311-29.
43. Angulo J, PeiróC, Sanchez-Ferrer CF, Gabancho S, Cuevas P, Gupta S, Sáenz de Tejada I. Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue. Br J Pharmacol 2001;134:1190-4J.
44. Angulo J, Cuevas P, Cuevas B, Bischoff E, Sáenz de Tejada I. Vardenafil reverses erectile dysfunction induced by paroxetine in rats. Int J Impot Res 2003;15:90-3.
45. Ahn GJ, Kang KK, Kim DS, Ahn BO, Kim WB, Kang SK, Lee BC, Hwang WS. DA-8159 reverses selective serotonin reuptake inhibitor-induced erectile dysfunction in rats. Urology 2005;65:202-7.
46. Lau DH, Thompson CS, Bellringer JF, Thomas PJ, Mumtaz FH, Morgan RJ, Mikhailidis DP. Doxazosin and serotonin (5-HT) receptor (1A, 2A, and 4) antagonists inhibit 5-HT-mediated human cavernosal contraction. J Androl 2006;27:679-85.
47. Labbate LA, Grimes J, Hines A, Oleshansky MA, Arana GW. Sexual dysfunction induced by selective serotonin reuptake antidepressants. J Sex Marital Ther 1998;24:3-12.
48. Mathew RJ, Weinman ML. Sexual dysfunctions in depression. Arch Sex Behav 1982;11:323-5.
49. Waldinger MD. The neurobiological approach to premature ejaculation. J Urol 2002;168:2359-67.
50. McIntosh TK, Barfield RJ. Brain monoaminergic control of male reproductive behavior. I. Serotonin and the post-ejaculatory refractory period. Behav Brain Res 1984;12:255-65.
51. Corona G, Mannucci E, Tannini EAJ, Lotti F, Ricca V, Monami M, Boddi V, Bandini E, Balercia G, Forti G, Maggi M. Hypoprolactinemia: A new clinical syndrome in patients with sexual dysfunction. J Sex Med 2009 [Epub ahead of print]doi: 10.1111/j.1743-6109.2008.01206.x.
52. Montgomery S, Doyle JJ, Stern L, McBurney CR. Economic considerations in the prescribing of third-generation antidepressants. Pharmacoeconomics 2005;23:477-91.
53. Ralph DJ, Wylie KR. Ejaculatory disorders and sexual function. BJU Int 2005;95:1181-6.
54. Rothschild AJ. Sexual side effects of antidepressants. J Clin Psychiatry 2000;11(51 suppl):28-36.
55. Corona G, Petrone L, Mannucci E, Magini A, Lotti F, Ricca V, Chiarini V, Forti G, Maggi M. Assessment of the relational factor in male patients consulting for sexual dysfunction: The concept of couple sexual dysfunction. J Androl 2006;27:795-801.